| Net Cash Provided by (Used in) Operating Activities |
-121K |
USD |
+30.7% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-37.6K |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
78.9M |
shares |
+6.07% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-159K |
USD |
+9.16% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
590K |
USD |
+37.9% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
6.12M |
USD |
+5.72% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
5.07M |
USD |
+5.41% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
45.4M |
USD |
+4.76% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |